Samrat Pharmachem Limited reported earnings results for the second quarter and six months ended September 30, 2021. For the second quarter, the company reported sales was INR 590.76 million compared to INR 414.97 million a year ago. Revenue was INR 591.49 million compared to INR 415.2 million a year ago. Net income was INR 27.9 million compared to INR 14.4 million a year ago. Basic earnings per share from continuing operations was INR 9.03 compared to INR 4.66 a year ago. Diluted earnings per share from continuing operations was INR 9.03 compared to INR 4.66 a year ago. For the six months, sales was INR 1,063.15 million compared to INR 767.64 million a year ago. Revenue was INR 1,065.41 million compared to INR 768.06 million a year ago. Net income was INR 37.43 million compared to INR 22.38 million a year ago. Basic earnings per share from continuing operations was INR 12.12 compared to INR 7.24 a year ago. Diluted earnings per share from continuing operations was INR 12.12 compared to INR 7.24 a year ago.